Recent advances in the understanding of autoantibody functionalities are bringing
neuroimmunologists closer to a more detailed appreciation of the mechanisms that govern …

Myasthenia gravis (MG) has been recognized as a series of heterogeneous but treatable
autoimmune conditions. As one of the indispensable therapies, thymectomy can achieve …

Objective To describe the clinical characteristics and outcomes in patients with refractory
myasthenia gravis (MG) and to determine the effectiveness and side effects of the drugs …

Pituitary autoimmunity is one of the principal causes of hypopituitarism. Additionally,
hypophysitis is one of the immune-related adverse events associated with immunotherapy …

Clinically, thymoma patients are often complicated with myasthenia gravis (MG).
Dexamethasone, a glucocorticoid with anti-inflammatory effects, could be used as an …

Background: Myasthenic crisis (MC) is a life-threatening condition for myasthenia gravis
(MG). Therapeutic plasma exchange (TPE) and intravenous immunoglobulin (IVIg) …

Background This study aimed to evaluate the prognosis of concurrent chemo-radiotherapy
(CCRT) versus sequential chemo-radiotherapy (SCRT) induction followed by surgical …

The thymus is a lymphoid organ involved in the differentiation of T cells, and has a central
role in the physiopathogenesis of Myasthenia Gravis (MG). This connection is proved by a …

Methods Diagnostic methods must be chosen accurately to avoid unnecessary surgical
resections, to define the best strategy of care, and to plan the surgical strategy. Therefore …

Abstract Introduction/Aims The Duke Myasthenia Gravis (MG) Clinic Registry contains
comprehensive physician‐derived data on patients with MG seen in the Duke MG Clinic …